Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Phase 3 REALIZE study shows milestone in treatment development for hepatitis C

Phase 3 REALIZE study shows milestone in treatment development for hepatitis C

Researchers identify eight clinical features for cancer

Researchers identify eight clinical features for cancer

Iron supplements reduce risk of iron deficiency and anemia in children with marginally low birth weights

Iron supplements reduce risk of iron deficiency and anemia in children with marginally low birth weights

Celgene receives Paragraph IV Certification Letter on submission of ANDA for REVLIMID

Celgene receives Paragraph IV Certification Letter on submission of ANDA for REVLIMID

Avoidance of fluoride reduces anemia in pregnant women and decreases pre-term births

Avoidance of fluoride reduces anemia in pregnant women and decreases pre-term births

Research finds link between chronic heart failure, iron deficiency

Research finds link between chronic heart failure, iron deficiency

Michigan, New York roll out high-risk pools

Michigan, New York roll out high-risk pools

Large clinical trial does not confirm benefits of erythropoieitin for first ST-elevation myocardial infarction

Large clinical trial does not confirm benefits of erythropoieitin for first ST-elevation myocardial infarction

Eight signs of cancer: Study

Eight signs of cancer: Study

David Mosser to discuss primary duty of macrophages at American Physiological Society conference

David Mosser to discuss primary duty of macrophages at American Physiological Society conference

Shire receives European marketing approval for VPRIV therapy to treat type 1 Gaucher disease

Shire receives European marketing approval for VPRIV therapy to treat type 1 Gaucher disease

H1N1 flu increases complication in children with sickle cell anemia: Study

H1N1 flu increases complication in children with sickle cell anemia: Study

Hemoglobin variability does not increase mortality in European hemodialysis patients: Study

Hemoglobin variability does not increase mortality in European hemodialysis patients: Study

FDA grants LFB's recombinant anti-CD20 monoclonal antibody orphan drug status for CLL

FDA grants LFB's recombinant anti-CD20 monoclonal antibody orphan drug status for CLL

FibroGen announces study results of recombinant human type III collagen in corneal damage

FibroGen announces study results of recombinant human type III collagen in corneal damage

Celgene to enforce REVLIMID intellectual property rights following receipt of Paragraph IV notification letter

Celgene to enforce REVLIMID intellectual property rights following receipt of Paragraph IV notification letter

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

Celgene receives Japan's MHLW approval for REVLIMID in deletion 5q myelodysplastic syndrome patients

Celgene receives Japan's MHLW approval for REVLIMID in deletion 5q myelodysplastic syndrome patients

FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD

FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD

Hematopoietic cell transplantation survivors report of  chronic health condition after procedure

Hematopoietic cell transplantation survivors report of chronic health condition after procedure

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.